Clinical Trial Update: Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the role of progesterone in hypoactive sexual desire disorder among menopausal women. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder
• Menopause

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Bezmialem Vakif University | Conditions: Menopause, Sexual Desire Disorder | Phase 4 | Status: UNKNOWN